Companies /Healthcare

Lilly(Eli) & Company

NYSE: LLY Drug Manufacturers - General
$1,189.41
▼ $44.25 (−3.59%) today
Markets closed · 7:56pm ET

LLY Coverage

Page 13
8:11am ET
Investing

3 Top Pharma Stocks to Buy in October 2024

The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we need it, to everyday pain remediation or allergy medications, big pharma companies…

Chris MacDonald
10:49am ET
Investing

VTI vs. VOO: Which ETF Should You Buy?

Diversification is key in today’s investing world. Exchange-traded funds, or ETFs, offer a convenient and affordable way to achieve this. Think of them as baskets filled with a variety of stocks. You…

Kristin Hitchcock
8:42am ET
Investing

QQQ vs. VOO: Which ETF Should You Buy?

247 Wall St. Key Insights QQQ offers higher growth potential but comes with greater risk due to its reliance on tech stocks. VOO provides broad market exposure with lower risk and steady…

Kristin Hitchcock
11:50am ET
Investing

Five Top Obesity Stocks to Buy and Hold Long Term

Some of the best opportunities can still be found in obesity treatment stocks. Look at Viking Therapeutics (NASDAQ:VKTX | VKTX Price Prediction), for example. Now trading at $57.80, we strongly believe it…

Ian Cooper
2:40pm ET
Investing

2 Weight Loss Drug Stocks Worth Stashing Away for Years

As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to the chin. Undoubtedly, several investment themes, including generative AI and GLP-1 (weight-loss)…

Joey Frenette
12:32pm ET
Investing

2 Biotech Bets to Buy in September

Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery process is…

Rich Duprey
4:37pm ET
Investing

Has Eli Lilly Destroyed Hims & Hers Upside?

Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole in Food & Drug Administration regulations to bring to market similar drugs…

Rich Duprey
9:12am ET
Investing

3 GLP-1 Stocks to Buy Now For Big Long-Term Gains

The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the growth various weight loss drugs have seen is notable, with GLP-1 agonists like Ozempic, Wegovy,…

Chris MacDonald